AAAAAA

   
Results: 1-11 |
Results: 11
TISSUE STORAGE OF HYDROXYETHYL STARCH (HES) - A TEMPORARILY LIMITED PHENOMENON
Authors: SIRTL C ZUMTOBEL V KRAFT D JURECKA W LAUBENTHAL H
Citation: C. Sirtl et al., TISSUE STORAGE OF HYDROXYETHYL STARCH (HES) - A TEMPORARILY LIMITED PHENOMENON, Anesthesiology, 1998, pp. 24-24
DESFLURANE FOR SEDATION OF VENTILATED PATIENTS
Authors: MEISER AR HUGLER P SIRTL C KAISER J LAUBENTHAL H
Citation: Ar. Meiser et al., DESFLURANE FOR SEDATION OF VENTILATED PATIENTS, Anesthesiology, 1998, pp. 27-27
SUPPRESSION OF INTERLEUKIN-2-RELEASE BY COLLOIDAL PLASMA SUBSTITUTES IN HUMAN WHOLE-BLOOD IN-VITRO
Authors: SIRTL C SALEWSKY G LAUBENTHAL H BAIER J NEUMANN HA
Citation: C. Sirtl et al., SUPPRESSION OF INTERLEUKIN-2-RELEASE BY COLLOIDAL PLASMA SUBSTITUTES IN HUMAN WHOLE-BLOOD IN-VITRO, Anesthesiology, 1998, pp. 28-28
DESFLURANE FOR SEDATION OF VENTILATED PATIENTS
Authors: MEISER AR HUGLER P SIRTL C KAISER J LAUBENTHAL H
Citation: Ar. Meiser et al., DESFLURANE FOR SEDATION OF VENTILATED PATIENTS, Anesthesiology, 89(3A), 1998, pp. 479-479
HYDROXYETHYL STARCH ANTIBODIES IN HUMANS - INCIDENCE AND CLINICAL RELEVANCE
Authors: DIETERICH HJ KRAFT D SIRTL C LAUBENTHAL H SCHIMETTA W POLZ W GERLACH E PETER K
Citation: Hj. Dieterich et al., HYDROXYETHYL STARCH ANTIBODIES IN HUMANS - INCIDENCE AND CLINICAL RELEVANCE, Anesthesia and analgesia, 86(5), 1998, pp. 1123-1126
PAIN TREATMENT AFTER SHOULDER SURGERY TOPICAL MORPHINE VS BUPIVACAINEVS PLACEBO
Authors: MEISER A SIRTL C WITTENBERG R LAUBENTHAL H
Citation: A. Meiser et al., PAIN TREATMENT AFTER SHOULDER SURGERY TOPICAL MORPHINE VS BUPIVACAINEVS PLACEBO, British Journal of Anaesthesia, 76, 1996, pp. 383-383
TISSUE STORAGE OF HYDROXYETHYL STARCH (HES) - A TEMPORARILY LIMITED PHENOMENON
Authors: SIRTL C KRAFT D ZUMTOBEL V JURECKA W LAUBENTHAL H
Citation: C. Sirtl et al., TISSUE STORAGE OF HYDROXYETHYL STARCH (HES) - A TEMPORARILY LIMITED PHENOMENON, Anesthesiology, 85(3A), 1996, pp. 255-255
THE INFLUENCE OF COLLOIDAL PLASMA SUBSTITUTES ON THE RELEASE OF IL-1-ALPHA AND IL-1-BETA IN HUMAN WHOLE-BLOOD IN-VITRO
Authors: SALEWSKY G SIRTL C BAIER J LAUBENTHAL H NEUMANN HA
Citation: G. Salewsky et al., THE INFLUENCE OF COLLOIDAL PLASMA SUBSTITUTES ON THE RELEASE OF IL-1-ALPHA AND IL-1-BETA IN HUMAN WHOLE-BLOOD IN-VITRO, Anesthesiology, 85(3A), 1996, pp. 557-557
THE INFLUENCE OF COLLOIDAL PLASMA SUBSTIT UTES ON THE RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HUMAN WHOLE-BLOOD IN-VITRO
Authors: SIRTL C SALEWSKY G BAIER J LANGE S LAUBENTHAL H NEUMANN HA
Citation: C. Sirtl et al., THE INFLUENCE OF COLLOIDAL PLASMA SUBSTIT UTES ON THE RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HUMAN WHOLE-BLOOD IN-VITRO, Infusionstherapie und Transfusionsmedizin, 22(6), 1995, pp. 332-338
RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA INDUCED BY ARTIFICIAL PLASMA SUBSTITUTES IN HUMAN WHOLE-BLOOD IN-VITRO
Authors: SIRTL C SALEWSKY G BAIER J NEUMANN HA LAUBENTHAL H
Citation: C. Sirtl et al., RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA INDUCED BY ARTIFICIAL PLASMA SUBSTITUTES IN HUMAN WHOLE-BLOOD IN-VITRO, Anesthesiology, 83(3A), 1995, pp. 311-311
WERNICKE ENCEPHALOPATHY - CAUSES TO CONSIDER
Authors: HEYE N TERSTEGGE K SIRTL C MCMONAGLE U SCHREIBER K MEYERGESSNER M
Citation: N. Heye et al., WERNICKE ENCEPHALOPATHY - CAUSES TO CONSIDER, Intensive care medicine, 20(4), 1994, pp. 282-286
Risultati: 1-11 |